Get the content you want anytime you want.
<< View All Contributors

Saskia v. Popescu - Page 3

Saskia v. Popescu, PhD, MPH, MA, CIC, is a hospital epidemiologist and infection preventionist. During her work as an infection preventionist, she performed surveillance for infectious diseases, preparedness, and Ebola-response practices. She holds a doctorate in Biodefense from George Mason University where her research focuses on the role of infection prevention in facilitating global health security efforts. She is certified in Infection Control and has worked in both pediatric and adult acute care facilities.
From an infection prevention perspective, the nature of Acinetobacter baumannii makes it an organism on the radar for prevention efforts against health care-associated infections.
A new study sheds light on how Pseudomonas aeruginosa might pick up resistance to phage therapy.
Since 2014 NYC Health + Hospitals has worked to maintain preparedness against diseases like Ebola. 
Assessing 195 countries’ capability to prepare, detect, and respond to outbreaks has found some major gaps.
Researchers stumbled upon a resistant mutation in group A Streptococcus that confers reduced susceptibility to β-lactam antibiotics.
What hurdles are companies facing in the pursuit of developing new antibiotics against multidrug-resistant organisms?
A new study points to an increased risk for infections in patients with PTSD.
The ECDC 2019 plan to address multi- and extensively-drug resistant gonorrhea has been released.
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?